State of Wyoming’s Amylyx Pharmaceuticals AMLX Stock Holding History

State of Wyoming’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.9K	Buy	2,223 +340	+18%	+$5.26K	﹤0.01%	1723
2026 Q1	$26.2K	Buy	1,883 +502	+36%	+$7.06K	﹤0.01%	1652
2025 Q4	$16.7K	Buy	+1,381	New	+$18.8K	﹤0.01%	1706
2025 Q2	–	Sell	-15,920	Closed	-$56.4K	–	1855
2025 Q1	$56.4K	Sell	15,920 -157	-1%	-$559	0.01%	1409
2024 Q4	$60.8K	Sell	16,077 -9,700	-38%	-$45.6K	0.01%	1341
2024 Q3	$83.5K	Sell	25,777 -36,007	-58%	-$80.9K	0.01%	1253
2024 Q2	$117K	Buy	+61,784	New	+$120K	0.02%	925

Other funds holding AMLX

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

IGAM

iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

CCIA

Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

FRM

Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return

State of Wyoming's AMLX Position: Q2 2026 in Review

State of Wyoming increased its Amylyx Pharmaceuticals (AMLX) stake by 18% in Q2 2026, buying an estimated $5.26K and bringing the position to 2,223 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1723.

State of Wyoming first reported a position in AMLX in Q2 2024 and has held it in 7 quarters since. The position peaked at $117K in Q2 2024. 42 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

State of Wyoming held 2,223 shares of Amylyx Pharmaceuticals worth $39.9K as of Q2 2026.
State of Wyoming bought 340 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $5.26K.
Amylyx Pharmaceuticals made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1723 holding.
State of Wyoming first reported a position in Amylyx Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
State of Wyoming's Amylyx Pharmaceuticals position peaked at $117K in Q2 2024.
42 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.